Primary Treatment of Light Chain (AL) Amyloidosis With Bortezomib, Lenalidomide and Dexamethasone (VRD) or with Bortezomib, Cyclophosphamide and Dexamethasone (VCD/CyBorD): efficacy and toxicity

Efstathios Kastritis; Maria Gavriatopoulou; Despina Fotiou; Nikolaos Kanellias; Magdalini Migkou; Maria Irini Tselegkidi; Smaragdi Marinaki; Erasmia Psimenou; Ioannis Ntanasis‐Stathopoulos; Harikleia Gakiopoulou; Αριστέα-Μαρία Παπανώτα; Evangelos Terpos; Meletios A Dimopoulos

doi:10.1016/j.clml.2019.09.526

Shared by

Meletios A Dimopoulos

Primary Treatment of Light Chain (AL) Amyloidosis With Bortezomib, Lenalidomide and Dexamethasone (VRD) or with Bortezomib, Cyclophosphamide and Dexamethasone (VCD/CyBorD): efficacy and toxicity

Article 2019 en

Authors

EK
Efstathios Kastritis
MG
Maria Gavriatopoulou
DF
Despina Fotiou

Discussion(0)

No comments yet. Be the first to comment.

Related publications

Article2018

Primary Treatment of Light Chain (AL) Amyloidosis with Bortezomib, Lenalidomide and Dexamethasone (VRD)

Eftathios Kastritis, Ioanna Dialoupi, Maria Gavriatopoulou, Μαρία Ρούσσου, Nikolaos Kanellias, Marini Tselegkidi, Elektra Papadopoulou, Dimitrios C. Ziogas, Κimon Stamatelopoulos, Efstathios Manios, Argyrios Ntalianis, Evangelos Eleutherakis‐Papaiakovou, Magdalini Migkou, Despina Fotiou, Asimina Papanikolaou, Charikleia Gakiopoulou, Erasmia Psimenou, Ioanna Tatouli, Ioannis Ntanasis‐Stathopoulos, Tina Bagratuni, Alexandra Papathoma, Marilyn Spyropoulou-Vlachou, Stavroula Giannouli, Evangelos Terpos, Meletios A Dimopoulos

Article2019

Primary Treatment of Light Chain (AL) Amyloidosis with Bortezomib, Lenalidomide and Dexamethasone (VRD)

Efstathios Kastritis, Ioanna Dialoupi, Maria Gavriatopoulou, Μαρία Ρούσσου, Nikolaos Kanellias, Despina Fotiou, Ioannis Ntanasis‐Stathopoulos, Elektra Papadopoulou, Dimitrios C. Ziogas, Κimon Stamatelopoulos, Efstathios Manios, Argyrios Ntalianis, Evangelos Eleutherakis‐Papaiakovou, Asimina Papanikolaou, Magdalini Migkou, Charikleia Gakiopoulou, Erasmia Psimenou, Marini Tselegkidi, Ourania Tsitsilonis, Ioannis P. Trougakos, Ioannis Kostopoulos, Evangelos Terpos, Meletios A Dimopoulos

Article2019

PS1393 PRIMARY TREATMENT OF LIGHT CHAIN (AL) AMYLOIDOSIS WITH BORTEZOMIB, LENALIDOMIDE AND DEXAMETHASONE (VRD)

Efstathios Kastritis, Ioanna Dialoupi, Maria Gavriatopoulou, Μαρία Ρούσσου, Nikolaos Kanellias, Despina Fotiou, Ioannis Ntanasis‐Stathopoulos, E. Eleutherakis‐Papaiakovou, Efstathios Manios, Magdalini Migkou, Dimitrios C. Ziogas, Αριστέα-Μαρία Παπανώτα, E. Papadopoulou, Kimon Stamatelopoulos, Argyrios Ntalianis, Asimina Papanikolaou, Charikleia Gakiopoulou, Erasmia Psimenou, M.E. Tselegkidi, Ourania Tsitsilonis, Ioannis P. Trougakos, Ioannis V. Kostopoulos, Evangelos Terpos,

Article2019

Primary treatment of light-chain amyloidosis with bortezomib, lenalidomide, and dexamethasone

Efstathios Kastritis, Ioanna Dialoupi, Maria Gavriatopoulou, Μαρία Ρούσσου, Nikolaos Kanellias, Despina Fotiou, Ioannis Ntanasis‐Stathopoulos, Elektra Papadopoulou, Dimitrios C. Ziogas, Κimon Stamatelopoulos, Efstathios Manios, Argyrios Ntalianis, Evangelos Eleutherakis‐Papaiakovou, Asimina Papanikolaou, Magdalini Migkou, Αριστέα-Μαρία Παπανώτα, Harikleia Gakiopoulou, Erasmia Psimenou, Maria Irini Tselegkidi, Ourania Tsitsilonis, Ioannis V. Kostopoulos, Evangelos Terpos, Meletios A Dimopoulos

Article2010

Bortezomib With or Without Dexamethasone in Primary Systemic (Light Chain) Amyloidosis

Efstathios Kastritis, Ashutosh Wechalekar, Meletios A Dimopoulos, Giampaolo Merlini, Philip N. Hawkins, Vittorio Perfetti, Julian D. Gillmore, Giovanni Palladini